Citation Impact

Citing Papers

Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis
1978
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
2002
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Rheumatoid arthritis
2018 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Thymus, innate immunity and autoimmune arthritis: Interplay of gene and environment
2011 StandoutNobel
When does rheumatoid arthritis begin and why do we need to know?
2000
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Prevention of Venous Thromboembolism in General Surgical Patients
1988
Spontaneous development of autoimmune arthritis due to genetic anomaly of T cell signal transduction: Part 1
2006 StandoutNobel
Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association?
2002
Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers
1994
Association of Periodontitis With Rheumatoid Arthritis: A Pilot Study
2010
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
Multimodal strategies to improve surgical outcome
2002 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Interactions between the Cytosolic Components p47 and p67 of the Human Neutrophil NADPH Oxidase That Are Not Required for Activation in the Cell-free System
1995
Prevention of VTE in Nonsurgical Patients
2012 Standout
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Intrauterine device and upper-genital-tract infection
2000
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
Animal models of arthritis caused by systemic alteration of the immune system
2005 StandoutNobel
Prevention of Venous Thromboembolism
2004 Standout
Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction
2001
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Rheumatoid arthritis
2010 Standout
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Prevention of Venous Thromboembolism
2008 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity
1999
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Polycystic ovary syndrome
2016 Standout
Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis
2008 StandoutNobel
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Prevention of Venous Thromboembolism
1998
Rheumatoid Arthritis Induced by α-Interferon Therapy
2001
The course of established rheumatoid arthritis
2007
1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology
1997
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
Nicotine withdrawal in chippers and regular smokers: Subjective and cognitive effects.
1995
Nicotine replacement therapy for smoking cessation
2012 Standout
PROPHYLAXIS AGAINST POSTOPERATIVE PULMONARY EMBOLISM AND DEEP-VEIN THROMBOSIS BY LOW-DOSE HEPARIN
1978
Prophylaxis of thromboembolism in pregnancy: an alternative
1985
Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.
2000
Selective Accumulation of Related CD4+ T Cell Clones in the Synovial Fluid of Patients with Rheumatoid Arthritis
1998
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding
2015
Prevention of Venous Thromboembolism
1992
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
Recycling of hard-core smokers with nicotine nasal spray
1996
State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy
1998
Prevention of Venous Thrombosis With Small, Subcutaneous Doses of Heparin
1976
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Ecological Momentary Assessment
2007 Standout
Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism
1999
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis
2002
Trends in the United States cesarean section rate and reasons for the 1980-85 rise.
1987 Standout
Are agents affecting platelet functions clinically useful?
1976
Prevention of venous thromboembolism after general surgery
1987
The Epidemiology of Venous Thromboembolism
2003 Standout
Epidemiology of Venous Thromboembolism
1977
Low-Molecular-Weight Heparins
1997 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low‐dose heparin
1980
Has use of cesarean section reduced the risks of delivery in the preterm breech presentation?
1986
Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
1979 StandoutNobel
RATES OF VENOUS THROMBOSIS AFTER GENERAL SURGERY: COMBINED RESULTS OF RANDOMISED CLINICAL TRIALS
1986
Prevention of Venous Thromboembolism
1995
Surgical approach to hysterectomy for benign gynaecological disease
2015 Standout
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives
1997
Venous thromboembolism prophylaxis in gynecologic oncology: A prospective, controlled trial of low-dose heparin
1983
Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.
1987
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Reduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
1982

Works of Terry McCarthy being referenced

The premature breech: trial of labor or cesarean section?
1979
Contraceptives for lactating women: A comparative trial of a progesterone-releasing vaginal ring and the Copper T 380A IUD
1997
Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices
1992
Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.
1995
Microdose intrauterine levonorgestrel for contraception
1987
Recovery of fertility after use of the Levonorgestrel 20 mcg/d or copper T 380 Ag intrauterine device
1986
An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine
1986
A COMPARISON OF LOW-DOSE SUBCUTANEOUS HEPARIN AND INTRAVENOUS DEXTRAN 70 IN THE PROPHYLAXIS OF DEEP VENOUS THROMBOSIS AFTER GYNECOLOGICAL SURGERY
1975
Two years of intrauterine contraception with levonorgestrel and with copper: A randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day device
1987
LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER GYNAECOLOGICAL SURGERY
1973
A COMPARISON OF LOW‐DOSE SUBCUTANEOUS HEPARIN AND INTRAVENOUS DEXTRAN 70 IN THE PROPHYLAXIS OF DEEP VENOUS THROMBOSIS AFTER GYNAECOLOGICAL SURGERY
1974
Rankless by CCL
2026